CANNABIS
Nabilone effective in reducing headache in medication overuse headach patients compared to ibuprofen
J Headache Pain. 2012 Nov;13(8):677-84. doi: 10.1007/s10194-012-0490-130 patients diagnosed with medication overuse headache were randomly assigned to receive either nabilone or ibuprofen for each treatment period. This cross-over study consisted of two 8-week treatment periods, each with 1 week of washout before, and a 2-week discontinuation period at the end of the study. Patients were assessed for the reduction in headache frequency, pain intensity, duration, daily analgesic intake, the incidence of adverse events, and quality of life. Results demonstrated that nabilone significantly reduced daily analgesic intake, headache pain and duration, and quality of life after each 8-week treatment period, while no serious adverse events were reported.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
